학술논문

Comparison of three-weekly and six-weekly pembrolizumab United Kingdom prescribing practice for advanced and resected melanoma
Document Type
Article
Source
In: European Journal of Cancer. (European Journal of Cancer, November 2023, 194)
Subject
Language
English
ISSN
18790852
09598049